Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration

Journal of Veterinary Pharmacology and Therapeutics

Volumn 19, Issue 1, 1996, Pages 56-61

  Schneider, M ^a   Thomas, V ^a   Boisrame, B ^a   Deleforge, J ^a  

^a Vetoquinol Research Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MARBOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; DRUG PENETRATION; DRUG TISSUE LEVEL; DRUG URINE LEVEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SKIN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029960252     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.1996.tb00009.x     Document Type: Article

References (12)

1. Courvalin, P., Drugeon, H., Flandrois, J.P. & Goldstein, F. (1990) Bactericidie: Aspects théoriques et thérapeutiques, pp. 200-202, Editions Maloine, Paris.
2. Carlotti, D.N. & Oavert, P. (1988) Utilisation de l'association amoxycilline-acide clavulanique dans le traitement des pyodermites du chien. Pratique Médicale et Chirurgicale de l'Animal de Compagnie, 23, 519-522.
3. Gibaldi, M. & Perrier, D. (1982) Pharmacokinetics, pp. 145-219, 2nd edn. Marcel Dekker, New York.
4. Guaguere, E. & Marc, J.P. (1988) Utilisation de la céfalexine dans le traitement des pyodermites. Pratique Médicale et Chirurgicale de l'Animal de Compagnie, 24, 124-129.
5. Hove, W., Lettow, E. & Opitz, M. (1992) Erfahrungen mit dem Antiinfektivum Enrofloxacin (Baytril) bei Pyodermien von Hund und Katze. Kieintierpraxis, 37, 817-822.
6. Ihrke, P.I. (1990) Bacterial infections of the skin. In Infectious diseases of the dog and cat. Ed C.E. Greene. pp. 72-79. W.B. Saunders, Philadelphia.
7. Koch, H.J. & Peters, S. (1992) Einsatz und Wirkung von Enrofloxacin bei bakteriellen Hauterkrankungen (Pyodermien) des Hundes. Der Praktische Tierarzt, 12, 1126-1138.
8. Küng, K., Riond, J.L. & Wanner, M. (1993) Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 16, 462-468.
9. Lees, G.E. & Forester, D.S. (1992) Update: bacterial urinary tract infections. In Kirk's current veterinary therapy, vol. XI. pp. 909-914. W.B. Saunders, Philadelphia.
10. Lloyd, D.H. (1992) Therapy for canine pyoderma. In Kirk's current veterinary therapy, vol. XI. p. 542. W.B. Saunders, Philadelphia.
11. Spreng, M., Deleforge, J., Thomas, V., Boisrame, B. & Drugeon, H. (1995) Pharmacodynamics of marbofloxacin in dogs and cats. Journal of Veterinary Pharmacology and Therapeutics, 18, 284-289.
12. Yamaoka, K., Nakagawa, T., Tanaka, H., Yasuhara, M., Okumara, K. & Hori, R. (1985) A nonlinear multiple regression program, Multi 2 (Bayes), based on Bayesian algorithm for microcomputers. Journal of Pharmacobio-Dynamics, 8, 246-256.